AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ALENDRONATE
9 registrations across 4 African markets— 6 active
Markets with ALENDRONATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| OSTEONATE 70MG TABLET; ORAL | 🇿🇼Zimbabwe | PHARMA DYNAMICS PTY LTD | active | Jul 2030 |
| FOSALEN Comprimé / 70 mg | 🇹🇳Tunisia | TERIAK | expired | Jul 2015 |
| CALIDRON Comprimé / 70 mg | 🇹🇳Tunisia | IBN AL BAYTAR | expired | Sept 2014 |
| FOSALEN Comprimé / 70 mg | 🇹🇳Tunisia | TERIAK | expired | Sept 2007 |
| ACIDE ALENDRONIQUE GT COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| Hovid Alendronate Tablets | 🇹🇿Tanzania | Hovid Bhd | active | — |
| FOSAMAX COMPRIME | 🇲🇦Morocco | — | active | — |
| ACIDE ALENDRONIQUE NORMON 70 MG COMPRIME | 🇲🇦Morocco | — | active | — |
| ADRONAT 70 MG COMPRIME | 🇲🇦Morocco | — | active | — |
ALENDRONATE in Africa — Regulatory Overview
ALENDRONATE is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Tanzania, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.